Lead sponsor
The Affiliated Hospital of Qingdao University
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
0
Active
48
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
2
Trials by status
Completed
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese SubjectsBMI 19-26Ph 1Completed32